Online
|
|
ek badi purani kahawat hai ki bina aag ke dhuwa nahi nikalta
andar andar kuch to khichdi pak rahi hai...
Rumours are always in market. Dont believe in any rumours. stand on your own decision....
There are rumours of a bonus from cipla. Any
further information you have on this subject?...
BSE Announcements on Cipla
Posted by :
MMB MessengerCipla Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on October 28, 2009, inter alia, to consider Unaudited Financial Results for second quarter ended September 30, 2009 (Q2). ...
Gold Mine
Posted by :
basit222It is a Gold mine for investors. I agree that its short to medium term target is around 400+, whereas I believe that its long term target is 1000. One has to have patience and hold it for long term.....
any expectation for Bonus in near future ? ...
Company History 2
Posted by : basit222
Cipla has joined a global initiative taken up by the Vatican in collaboration with global generic pharmaceutical manufacturers and the International Federation of Catholic Pharmacies and Academics to float CUMVIVIUM.
The company launched a new treatment for arthritis in technical collaboration with California-based Cymbiotics Inc. During the period 2005, Cipla sets up state-of-the-art facility for manufacture of formulations at Baddi, Himachal Pradesh. As of February 2007, the company has entered into a development and supply agreement with Drugs for Neglected Diseases Initiative (DNDi), a global non-profit organisation, for a new anti-malarial combination drug as a global initiative. Cipla overtook Ranbaxy and GlaxoSmithKline India (GSK) to become the largest pharmaceutical company in the domestic market for the first time in May 2007 and Cipla scores a generic win over Swiss drug major Roche for manufacturing and selling generic versions of its patented anti-cancer drug Tarceva (Erlotinib) in India in 2008....
Company History
Posted by : basit222Dr. Khwaja Abdul Hamied founded The Chemical, Industrial & Pharmaceutical Laboratories at Mumbai, which came to be popularly known as Cipla. He gave the company all his patent and proprietary formulas for several drugs and medicines, without charging any royalty. On August 17, 1935, Cipla was registered as a public limited company. Cipla was officially opened on September 22, 1937 when the first products were ready for the market and now over 170 countries buy Cipla`s products. Cipla`s products & services are categorized into Prescription, Animal Products, OTC, Bulk Drugs, Flavours & Fragrances, Agrochemicals and Technology. As the Second World War cuts off drug supplies, the company starts producing fine chemicals, dedicating all its facilities for the war effort in 1941. The government accepted Dr. Hamied`s blueprint for a technical industrial research institute in 1942, and led to the birth of the Council of Scientific and Industrial Research (CSIR), which is today the zenith research body in the country. In 1944, the company bought the premises at Bombay Central and decided to put up a "first class modern pharmaceutical works and laboratory." It was also decided to acquire land and buildings at Vikhroli. With severe import restrictions hampering production, the company decided to commence manufacturing the basic chemicals required for pharmaceuticals. Cipla`s product for hypertension, Serpinoid, was exported to the American Roland Corporation, to the tune of Rs 8 Lakhs during the year 1946. The company had lay down the first research division for attaining self-sufficiency in technological development during the period of 1952 and the company entered into an agreement with a Swiss firm for manufacturing foromycene. In 1960 the company started its operations at second plant at Vikhroli, Mumbai, producing fine chemicals with special emphasis on natural products and the Vikhroli factory was started its manufacturing of diosgenin in 1961. This heralded the manufacture of several steroids and hormones derived from diosgenin. Cipla manufactures ampicillin in 1968; it was the first time of its kind in the country. The Agricultural Research Division at Bangalore was commenced to vigorous in 1972, for the purpose of scientific cultivation of medicinal plants. Cipla launched the medicinal aerosols for asthma, wins Chemexcil Award for Excellence for exports and the fourth factory begins operations at Patalganga, Maharashtra during the periods of 1976, 1980 and 1982 respectively. The name of the Company was changed from The Chemical Industrial & Pharmaceutical Laboratories Ltd., to the present one Cipla Ltd in July 1984 and Cipla Developed anti-cancer drugs, vinblastine and vincristine in collaboration with the National Chemical Laboratory, Pune. Wins Sir P C Ray Award for developing in-house technology for indigenous manufacture of a number of basic drugs. In 1988, Cipla wins the National Award for Successful Commercialisation of Publicly Funded R&D. Cipla launched etoposide; a breakthrough in cancer chemotherapy by association with Indian Institute of Chemical Technology in 1991 and the company pioneers the manufacture of the antiretroviral drug, zidovudine, in technological collaboration with Indian Institute of Chemical Technology, Hyderabad. The fifth factory of the company was started its commercial production at Kurkumbh, Maharashtra in the year 1994. As a social responsibility, the company sets up the palliative cancer care centre through its Foundation, begins offering free services in the year 1997 at Warje, near Pune. In 1998 the company launched the product lamivudine, becomes one of the few companies in the world to offer all three-component drugs of retroviral combination therapy (zidovudine and stavudine already launched). Launched Nevirapine, antiretroviral drug by the company in 1999, it used to prevent the transmission of AIDS from mother to child. Cipla and Ranbaxy have entered into a strategic partnership in the same year 1999 to jointly market a select basket of drugs. The alliance helped their strengths in the strongly emerging cardiovascular and perennial anti-infectives market. During the period 2000, Cipla became the first company, outside the USA and Europe to launch CFC-free inhalers - ten years before the deadline to phase out use of CFC in medicinal products. Four state-of-the-art manufacturing facilities sets up in Goa in a record time of less than twelve months in the year 2002 and the second phase of manufacturing operations at Goa was commissioned in 2003. The company launched TIOVA (Tiotropium bromide), a novel inhaled, long-acting anticholinergic bronchodilator that is employed as a once-daily maintenance treatment for patients with chronic obstructive pulmonary disease (COPD). In 2004, the company signed a long-term agreement with Morton Grove Pharmaceuticals Inc (MGP) of Illinois, US, for launch the product in US market and made alliance with Avesthagen forges....
Split or Bonus
Posted by : basit222Split or Bonus unlikely to move - given the recent example of RIL... I guess, one has to wait for some time to see up-word movement.....
Buy Cipla
Posted by : rajkishore420
Dear Pratap,
Check out for Monday. If the market is positive and the stock rises above 300 then keep it. Else dispose it so that the money can be suitably deployed elsewhere in low risk stocks.
Regards
RK...
buy & hold
Posted by : naugtyboythe temp dip is a good time to buy- target 325 oct end...
